Trial · NCT02853370
Adverse events24
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 24
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Bendamustine and Rituximab | 24 | 56 | 42 |
| other | Leukopenia | Blood and lymphatic system disorders | Bendamustine and Rituximab | 28 | 56 | 82 |
| other | Neutropenia | Blood and lymphatic system disorders | Bendamustine and Rituximab | 31 | 56 | 98 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Bendamustine and Rituximab | 26 | 56 | 51 |
| other | Investigations | Investigations | Bendamustine and Rituximab | 3 | 56 | 4 |
| other | Respiratory, thoracic and mediastinal disorders | Respiratory, thoracic and mediastinal disorders | Bendamustine and Rituximab | 4 | 56 | 10 |
| other | Nervous system disorders | Nervous system disorders | Bendamustine and Rituximab | 3 | 56 | 3 |
| other | General disorders and administration site conditions | General disorders | Bendamustine and Rituximab | 13 | 56 | 22 |
| other | Gastrointestinal disorders | Gastrointestinal disorders | Bendamustine and Rituximab | 23 | 56 | 37 |
| other | Skin disorder | Skin and subcutaneous tissue disorders | Bendamustine and Rituximab | 10 | 56 | 19 |
| other | Infections | Infections and infestations | Bendamustine and Rituximab | 7 | 56 | 17 |
| serious | Angioplasty | Surgical and medical procedures | Bendamustine and Rituximab | 1 | 56 | 1 |
| serious | Pancytopenia | Investigations | Bendamustine and Rituximab | 1 | 56 | 1 |
| serious | Malignant peripheral nerve sheath tumor | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Bendamustine and Rituximab | 1 | 56 | 1 |
| serious | Myelodysplastic syndrome | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Bendamustine and Rituximab | 1 | 56 | 1 |
| serious | Coagulation disorders | Blood and lymphatic system disorders | Bendamustine and Rituximab | 1 | 56 | 1 |
| serious | Febrile neutropenia | Blood and lymphatic system disorders | Bendamustine and Rituximab | 4 | 56 | 5 |
| serious | Anaemia | Blood and lymphatic system disorders | Bendamustine and Rituximab | 1 | 56 | 1 |
| serious | Infusion related reaction | General disorders | Bendamustine and Rituximab | 1 | 56 | 2 |
| serious | Paraneoplastic fever | General disorders | Bendamustine and Rituximab | 1 | 56 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02853370/events